Cart
sales@molnova.com
Home - Products - Endocrinology/Hormones - Opioid Receptor - Alvimopan dihydrate

Alvimopan dihydrate

CAS No. 170098-38-1

Alvimopan dihydrate( Alvimopan Dihydrate | Entereg | Alvimopan hydrate | LY 246736 dihydrate )

Catalog No. M12598 CAS No. 170098-38-1

A selective peripherally acting μ-opioid antagonist with IC50 of 1.7 nM for the treatment of postoperative ileus; prevents gastrointestinal effects of intravenous morphine without affecting analgesia; orally active.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 510 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Alvimopan dihydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    A selective peripherally acting μ-opioid antagonist with IC50 of 1.7 nM for the treatment of postoperative ileus; prevents gastrointestinal effects of intravenous morphine without affecting analgesia; orally active.
  • Description
    A selective peripherally acting μ-opioid antagonist with IC50 of 1.7 nM for the treatment of postoperative ileus; prevents gastrointestinal effects of intravenous morphine without affecting analgesia; orally active.Other Indication Approved.
  • In Vitro
    Alvimopan inhibits the loperamide-stimulated [35S]GTPγS binding to membranes containing the cloned human μ-opioid receptor, with an IC50 of 1.7 nM.
  • In Vivo
    Alvimopan (0.1-1.0 mg/kg; p.o.) partially antagonizes the slowing of small intestinal transit of 113Sn-labelled microspheres in rats.Alvimopan (3 mg/kg; p.o.) has no effect on the visceromotor behavioural responses (VMR) induced by noxious colorectal distension (CRD) in conscious rats.
  • Synonyms
    Alvimopan Dihydrate | Entereg | Alvimopan hydrate | LY 246736 dihydrate
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    170098-38-1
  • Formula Weight
    460.5631
  • Molecular Formula
    C25H36N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(O)CNC([C@@H](CC1=CC=CC=C1)CN2C[C@H](C)[C@](C)(C3=CC=CC(O)=C3)CC2)=O.[H]O[H].[H]O[H]
  • Chemical Name
    Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-, hydrate (1:2)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fukuda H, et al. Brain Res. 2006 Aug 2;1102(1):63-70. 2. Taguchi A, et al. N Engl J Med. 2001 Sep 27;345(13):935-40. 3. Schmidt WK. Am J Surg. 2001 Nov;182(5A Suppl):27S-38S.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • IPAG

    IPAG is a potent σ-receptor antagonist (pKi=4.3). IPAG can induce cell apoptosis.

  • CP-866087

    CP-866087 is a novel, potent and selective mu-opioid receptor antagonist for the study of female sexual dysfunction.

  • [Arg14,Lys15]Nocicep...

    Highly potent and selective NOP receptor agonist (EC50 = 1 nM). Displays > 875-fold selectivity over opioid receptors (IC50 values are 0.32, 280, > 10000 and 1500 for NOP, μ, δ and κ receptors respectively). Longer lasting and 30-fold more potent than nociceptin in vivo; pronociceptive and inhibits locomotor activity.

Sign In Join Free